Using the immune system as a defence against cancer

cancer cell
Credit: CC0 Public Domain

Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.

Several teams led by Professor Livio Mallucci from King's College London discovered that β-galactoside-binding protein (βGBP), a naturally occurring molecule produced by can non-specifically target , make them undergo and through a stress response pathway make the cancer cells visible to the immune system to prompt an anti-cancer immune response that would secure protection against recurrences.

Major developments in anti-cancer therapies have taken place over the last decade, but as only a subset of patients respond to treatments, there is a need for further development. Crucially, there is a need to induce the immune system to ensure long-term protection against the recurrence of cancer.

Current approaches to achieve this involve killing cells by using chemotherapeutics and other agents which can be harmful and have uncertain outcomes.

"By contrast, the anti-tumour property of βGBP is selective and not harmful to normal cells. βGBP is effective against the most aggressive colorectal cancer cells and a wide range of other cancer cells equally unresponsive to current therapies. This research presents experimental evidence for a strategy where the targeting of cancer cells and the stimulation of immunity combine to prompt immediate and long-term responses against aggressive cancer," said lead author Professor Livio Mallucci from King's College London, School of Cancer & Pharmaceutical Sciences.

"Translation of βGBP to the clinic could open a new therapeutic opportunity which safely combines direct killing of cancer cells and the stimulation of the against recurrences, a significant step forward in the management of cancer."


Explore further

Immune discovery set to boost cancer therapies, study suggests

Journal information: British Journal of Cancer

Citation: Using the immune system as a defence against cancer (2019, September 26) retrieved 15 November 2019 from https://medicalxpress.com/news/2019-09-immune-defence-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments